93 related articles for article (PubMed ID: 12489251)
1. Evaluation of the combined effect of pranlukast during high-dose steroid inhalation.
Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Sasaki Y; Banno K; Handa M
Arzneimittelforschung; 2002; 52(11):813-6. PubMed ID: 12489251
[TBL] [Abstract][Full Text] [Related]
2. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
[TBL] [Abstract][Full Text] [Related]
3. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
Ponticiello A; Vatrella A; Parrella R; Romano L; Zofra S; Berlingieri GM; Bariffi F
Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Ito T
Arzneimittelforschung; 2003; 53(10):714-21. PubMed ID: 14650364
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
[TBL] [Abstract][Full Text] [Related]
6. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
Tomita K; Hashimoto K; Matsumoto S; Nakamoto N; Tokuyasu H; Yamasaki A; Yajima H; Sasaki T; Kawasaki Y; Fukutani K
Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.
Dal Negro R; Micheletto C; Tognella S; Mauroner L; Burti E; Turco P; Pomari C; Cantini L
J Investig Allergol Clin Immunol; 1999; 9(4):241-7. PubMed ID: 10513351
[TBL] [Abstract][Full Text] [Related]
8. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
Hashimoto M; Fujishima T; Tanaka H; Kon H; Saikai T; Suzuki A; Nakatsugawa M; Abe S
Intern Med; 2001 May; 40(5):432-4. PubMed ID: 11393418
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
11. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
[TBL] [Abstract][Full Text] [Related]
12. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
[TBL] [Abstract][Full Text] [Related]
14. Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma.
Horiguchi T; Tachikawa S; Kasahara J; Doi M; Shiga M
Arzneimittelforschung; 1999 Jan; 49(1):35-7. PubMed ID: 10028377
[TBL] [Abstract][Full Text] [Related]
15. Effect of pranlukast on bronchial inflammation in patients with asthma.
Yoshida S; Ishizaki Y; Shoji T; Onuma K; Nakagawa H; Nakabayashi M; Akahori K; Hasegawa H; Amayasu H
Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924
[TBL] [Abstract][Full Text] [Related]
16. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
17. Step-down and step-up therapy in moderate persistent asthma.
Adachi M; Kohno Y; Minoguchi K
Int Arch Allergy Immunol; 2001; 124(1-3):414-6. PubMed ID: 11307032
[TBL] [Abstract][Full Text] [Related]
18. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
19. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
